To include your compound in the COVID-19 Resource Center, submit it here.

GI-5005: Preliminary Phase IIb data

Preliminary data from an open-label Phase IIb trial in 27 patients with the T/T genotype of interleukin-28B (IL-28B; IFNL3) showed

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE